Abstract:Background: Histopathological assessment of transplant biopsies is currently the standard method to diagnose allograft rejection and can help guide patient management, but it is one of the most challenging areas of pathology, requiring considerable expertise, time, and effort. We aimed to analyse the utility of deep learning to preclassify histology of kidney allograft biopsies into three main broad categories (ie, normal, rejection, and other diseases) as a potential biopsy triage system focusing on transplant rejection. Methods: We performed a retrospective, multicentre, proof-of-concept study using 5844 digital whole slide images of kidney allograft biopsies from 1948 patients. Kidney allograft biopsy samples were identified by a database search in the Departments of Pathology of the Amsterdam UMC, Amsterdam, Netherlands (1130 patients) and the University Medical Center Utrecht, Utrecht, Netherlands (717 patients). 101 consecutive kidney transplant biopsies were identified in the archive of the Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany. Convolutional neural networks (CNNs) were trained to classify allograft biopsies as normal, rejection, or other diseases. Three times cross-validation (1847 patients) and deployment on an external real-world cohort (101 patients) were used for validation. Area under the receiver operating characteristic curve (AUROC) was used as the main performance metric (the primary endpoint to assess CNN performance). Findings: Serial CNNs, first classifying kidney allograft biopsies as normal (AUROC 0·87 [ten times bootstrapped CI 0·85-0·88]) and disease (0·87 [0·86-0·88]), followed by a second CNN classifying biopsies classified as disease into rejection (0·75 [0·73-0·76]) and other diseases (0·75 [0·72-0·77]), showed similar AUROC in cross-validation and deployment on independent real-world data (first CNN normal AUROC 0·83 [0·80-0·85], disease 0·83 [0·73-0·91]; second CNN rejection 0·61 [0·51-0·70], other diseases 0·61 [0·50-0·74]). A single CNN classifying biopsies as normal, rejection, or other diseases showed similar performance in cross-validation (normal AUROC 0·80 [0·73-0·84], rejection 0·76 [0·66-0·80], other diseases 0·50 [0·36-0·57]) and generalised well for normal and rejection classes in the real-world data. Visualisation techniques highlighted rejection-relevant areas of biopsies in the tubulointerstitium. Interpretation: This study showed that deep learning-based classification of transplant biopsies could support pathological diagnostics of kidney allograft rejection. Funding: European Research Council; German Research Foundation; German Federal Ministries of Education and Research, Health, and Economic Affairs and Energy; Dutch Kidney Foundation; Human(e) AI Research Priority Area of the University of Amsterdam; and Max-Eder Programme of German Cancer Aid.

Explainability of a Deep Learning-Based Classification Model for ANCA-Associated Glomerulonephritis

Deep learning-enabled classification of kidney allograft rejection on whole slide histopathologic images

Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study

Identification of glomerular lesions and intrinsic glomerular cell types in kidney diseases via deep learning

Towards Accurate and Efficient Diagnoses in Nephropathology: An AI-Based Approach for Assessing Kidney Transplant Rejection

Investigation on explainable machine learning models to predict chronic kidney diseases

Automated recognition of glomerular lesions in the kidneys of mice by using deep learning

Deep Learning-Based Artificial Intelligence System for Automatic Assessment of Glomerular Pathological Findings in Lupus Nephritis

A Comparative Study of Explainability Methods for Whole Slide Classification of Lymph Node Metastases using Vision Transformers

An Explainable AI Paradigm for Alzheimer's Diagnosis Using Deep Transfer Learning

The Clinical Value of Explainable Deep Learning for Diagnosing Fungal Keratitis Using in vivo Confocal Microscopy Images

Artificial intelligence assists identification and pathologic classification of glomerular lesions in patients with diabetic nephropathy

Recognition of intraglomerular histological features with deep learning in protocol transplant biopsies and their association with kidney function and prognosis

Explainable Artificial Intelligence (XAI) for Deep Learning Based Medical Imaging Classification

Cherry on Top or Real Need? A Review of Explainable Machine Learning in Kidney Transplantation

Explainable convolutional neural networks for assessing head and neck cancer histopathology

Explainable AI for Glaucoma Prediction Analysis to Understand Risk Factors in Treatment Planning

Advancing Dermatological Diagnostics: Interpretable AI for Enhanced Skin Lesion Classification

ExplAIn: Explanatory Artificial Intelligence for Diabetic Retinopathy Diagnosis

Explainable synthetic image generation to improve risk assessment of rare pediatric heart transplant rejection

Explainable Deep Image Classifiers for Skin Lesion Diagnosis